Synergistic Ciprofloxacin-RWn Peptide Therapy Overcomes Drug Resistance in Gram-Negative Bacteria
ACS Omega · 19.08.2025 · 10 (32) · 35698-35705
DOI: 10.1021/acsomega.5c02285 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 30.06.2025. Verfasst von Bashiyar Almarwani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Tennessee State University, Nashville, Tennessee 37209, United States. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Xavier University of Louisiana.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Biology, Tennessee State University, Nashville, Tennessee 37209, United States.
- Department of Chemistry, Tennessee State University, Nashville, Tennessee 37209, United States.
- Department of Physics, Xavier University of Louisiana, New Orleans, Louisiana 70125, United States.
ORCID-Profile: Anderson Sunda-Meya
Förderung
- Wellcome Trust
- Xavier University of Louisiana
Zitieren
APA
Almarwani, B., Phambu, N., & Sunda-Meya, A. (2025). Synergistic Ciprofloxacin-RWn Peptide Therapy Overcomes Drug Resistance in Gram-Negative Bacteria. ACS Omega, 10(32), 35698-35705. https://doi.org/10.1021/acsomega.5c02285
Vancouver
Almarwani B, Phambu N, Sunda-Meya A. Synergistic Ciprofloxacin-RWn Peptide Therapy Overcomes Drug Resistance in Gram-Negative Bacteria. ACS Omega. 2025;10(32):35698-35705. doi:10.1021/acsomega.5c02285
BibTeX
@article{Almarwani2025,
author = {Almarwani, Bashiyar and Phambu, Nsoki and Sunda-Meya, Anderson},
title = {Synergistic Ciprofloxacin-RWn Peptide Therapy Overcomes Drug Resistance in Gram-Negative Bacteria},
journal = {ACS Omega},
year = {2025},
volume = {10},
number = {32},
pages = {35698--35705},
doi = {10.1021/acsomega.5c02285}
}
EUVIMED